Skip to main content
Premium Trial:

Request an Annual Quote

People in the News at OraSure, Element Biosciences, Micronoma, More

OraSure Technologies: Carrie Eglinton Manner, Nancy Gagliano, Kathleen Weber

OraSure Technologies has appointed Carrie Eglinton Manner to the role of president and CEO, replacing interim CEO Nancy Gagliano, according to a filing with the US Securities and Exchange Commission. Prior to joining OraSure, Eglinton Manner served as senior VP of advanced and general diagnostic and clinical solutions at Quest Diagnostics since January 2017. Prior to Quest, she served in various leadership roles at GE Healthcare, including as president and CEO of four distinct GE Healthcare global businesses in the areas of diagnostic imaging, lab services, and medical devices.

In connection with Eglinton Manner's appointment, Gagliano will resign from her position effective June 4.

In addition, Kathleen Weber, OraSure's president of molecular solutions, has also informed the company that she will resign. Pursuant to the terms of her employment, her resignation is planned for Aug. 21.

Element Biosciences: Mark Aitkenhead

Element Biosciences has appointed Mark Aitkenhead as its chief commercial officer. Aitkenhead joins Element from Thermo Fisher Scientific, where he has worked since 2003 and most recently served as the general manager for cellular analysis instrumentation and global commercial leader for the clinical next-generation sequencing division. He received both his Ph.D. in anatomy and a bachelor’s degree in biomedical sciences from The Queen’s University of Belfast in Northern Ireland.

Micronoma: Todd Czerwinski

Micronoma, a San Diego-based biotech company specializing in microbiome-based liquid biopsy for cancer diagnosis, has appointed Todd Czerwinski as VP of business development. Czerwinski has previously served as senior director of sales at DNA Genotek, as well as national sales/manager/global OEM accounts manager at Mo Bio and subsequently Qiagen, which acquired Mo Bio.

For additional recent items on executive appointments, promotions, and departures in omics and molecular diagnostics, please see the People in the News page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.